Thermo to Buy Back $300M of its Common Stock Mar 01, 2007 Save for later NEW YORK (GenomeWeb News) — Thermo Electron today said it will buy back $300 million shares of its common stock either in the open market or through negotiated deals through Feb. 28. Breaking News BforCure Gets CE Mark for 48-Well Flu/COVID Test Kit Cue Health to Lay Off 170 People Cepheid, BioGX to Jointly Develop Monkeypox PCR Test for GeneXpert System OpGen Enters At-Market Agreement to Sell up to $10.7M in Stock Top Five Articles on GenomeWeb Last Week: Illumina Acquiring IDbyDNA, Axbio Raising $100M, More The Scan Boosters Chasing Variants The New York Times reports that an FDA advisory panel is to weigh updated booster vaccines for COVID-19. Not Yet The World Health Organization says monkeypox is not yet a global emergency, the Washington Post reports. More Proposed for Federal Research Science reports that US House of Representatives panels are seeking to increase federal research funding. PLOS Papers on Breast Cancer Metastasis, Left-Sided Cardiac Defects, SARS-CoV-2 Monitoring In PLOS this week: link between breast cancer metastasis and CLIC4, sequencing analysis of left-sided cardiac defects, and more. What's Popular? Illumina Acquires IDbyDNA Monkeypox Genome Analysis Points to Single Origin of Recent Outbreak New York Genome Center Developing WGS Tests for Women's Health Premium New Products Posted to GenomeWeb: Illumina, Yourgene Health, Meridian Bioscience Molecular Tumor Profiling Benefits Pediatric Cancer Patients, Study Finds
